Extendicare (EXE) Competitors

Extendicare (TSE:EXE) and dentalcorp (TSE:DNTL) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, risk, community ranking, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability.

Do analysts rate EXE or DNTL?

Extendicare currently has a consensus target price of C$13.50, suggesting a potential downside of 5.73%. dentalcorp has a consensus target price of C$12.59, suggesting a potential upside of 46.61%. Given dentalcorp's stronger consensus rating and higher probable upside, analysts clearly believe dentalcorp is more favorable than Extendicare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Extendicare	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
dentalcorp	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media prefer EXE or DNTL?

In the previous week, Extendicare's average media sentiment score of 0.00 equaled dentalcorp'saverage media sentiment score.

Company	Overall Sentiment
Extendicare	Neutral
dentalcorp	Neutral

Which has better earnings and valuation, EXE or DNTL?

Extendicare has higher earnings, but lower revenue than dentalcorp. dentalcorp is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Extendicare	C$1.46B	0.82	C$65.46M	C$0.78	18.26
dentalcorp	C$1.49B	1.08	-C$80.68M	-C$0.43	-19.97

Is EXE or DNTL more profitable?

Extendicare has a net margin of 4.48% compared to dentalcorp's net margin of -5.40%. Extendicare's return on equity of 64.13% beat dentalcorp's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Extendicare	4.48%	64.13%	7.16%
dentalcorp	-5.40%	-4.71%	0.77%

Do insiders and institutionals hold more shares of EXE or DNTL?

19.2% of Extendicare shares are owned by institutional investors. Comparatively, 50.3% of dentalcorp shares are owned by institutional investors. 13.9% of Extendicare shares are owned by insiders. Comparatively, 0.2% of dentalcorp shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Which has more risk & volatility, EXE or DNTL?

Extendicare has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500. Comparatively, dentalcorp has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500.

Does the MarketBeat Community prefer EXE or DNTL?

Extendicare received 114 more outperform votes than dentalcorp when rated by MarketBeat users. However, 66.07% of users gave dentalcorp an outperform vote while only 47.04% of users gave Extendicare an outperform vote.

Company	Underperform	Outperform
Extendicare	Outperform Votes 151 47.04%	Underperform Votes 170 52.96%
dentalcorp	Outperform Votes 37 66.07%	Underperform Votes 19 33.93%

Summary

Extendicare beats dentalcorp on 8 of the 15 factors compared between the two stocks.